Top Markets
#1 Helium Helium +108.34%
#2 MowCat MowCat +101.34%
#3 Seeker Seeker +77.99%
#4 AI XOVIA AI XOVIA +45.07%
#5 Pons Pons +39.63%
#6 UnifAI Network UnifAI Network +33.66%
#7 Bounce Bounce +32.28%
#8 Tensor Tensor +23.04%
#9 Zylo Ecosystem Zylo Ecosystem +21.68%
#10 pipedog pipedog +21.23%
Coin of the day
Helium Helium
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Ergomed plc Ergomed plc

Ergomed plc

2EM
Rang in Aktien #11481
Ergomed plc, alongside its affiliated entities, offers a comprehensive range of... Ergomed plc, alongside its affiliated entities, offers a comprehensive range of clinical trial services, encompassing planning, oversight, and execution, in addition to providing essential drug safety and medical information support. The company maintains an expansive global footprint, conducting operations throughout the United Kingdom, continental Europe, the Middle East, Africa, North America, Asia, and Australia. Its business is organized into two core divisions: Clinical Research Services and Pharmacovigilance. Ergomed assists pharmaceutical, biotechnology, and generic drug manufacturers by managing clinical development programs, facilitating post-market approval strategies, and delivering robust pharmacovigilance solutions. Their expertise is concentrated in several therapeutic domains, including oncology, haematology, allergy, respiratory, and neurology/CNS, with a notable specialization in the development of orphan drugs. Furthermore, they extend support services to clinical trial sites. Established in 1997, the organization originally traded as Ergomed Clinical Research Limited before rebranding as Ergomed plc in June 2014. Its corporate headquarters are situated in Guildford, United Kingdom.
Aktienkurs
$13.05
Zuletzt synchronisiert: 2023-03-31
Marktkapitalisierung
$695.07M
Veränderung (1 Tag)
4.59%
Veränderung (1 Jahr)
0.00%
Land
GB
Handel Ergomed plc (2EM)

Kategorie

Healthcare
Dividendenhistorie für Ergomed plc (2EM)
Ergomed plc (Aktienkürzel: 2EM) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für Ergomed plc (2EM) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Dividendenzahlungen Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH